In adults, stem cells are created in the bone marrow and then distributed to the rest of the body through the blood system. It stands to reason that stem cells might be harvested from either location, but there is an important difference both in quantity and in quality between the stem cells found at the source and those found on the periphery of the body.
Barely twelve months ago, the University of California San Diego opened their $127,000,000 stem cell research center to a blitz of media hoopla. And yet, just a few miles down the road, ProgenCell had already spent more than a decade quietly bringing stem cells to patients who need them. What might explain such a contrast?
One of the usual complications of diabetes is the breakdown of the blood vessels that feed the retina, which is the part of the eye that processes images. Retinopathy occurs when blood leaks out of those vessels into the eye, causing blurred vision and ultimately blindness. Eighty percent of all patients who have suffered from diabetes for ten years develop diabetic retinopathy as a consequence.
Over the twelve years that we have been helping people with stem cell therapy in Tijuana, we have noticed an interesting phenomenon in our patients’ recoveries. With every treatment, the patient’s bone marrow produces more stem cells than it did the time before.
For the first treatment, we have measured an average of 8,520,000 units per milliliter.
As a major part of our commitment to total quality management and ISO9000 procedures, we have been developing ways to measure customer satisfaction. We do this in order to understand our patients better. Since we’re in the wellness business, success usually means that we don’t see our patient again, so we use what we learn while our patients are with us so that the experiences of our next patients can be even better.
